BRCA2 and neoplasm: As previously observed, tumor volume was significantly reduced in response to NVB in mice bearing KPC Brca2 KO cells; however, the antitumor efficacy of NVB was significantly impaired in STING-depleted tumors (Fig. 8g; Supplementary Fig. 7c).